Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of nalbuphine to prevent sufentanil-induced cough during general anesthesia induction
ChiCTR1900024382Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Cough reaction rate and Cough reaction severity. Started Jul 2019; status: recruiting.
02
Drugs
nalbuphine
Beyond the preview
Go deeper on ChiCTR1900024382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024382.